GV 2019 GP, L.L.C.'s Net Worth

$215 Million

Estimate Recalculated Jul 2, 2024 06:31AM EST

Who is GV 2019 GP, L.L.C.?

GV 2019 GP, L.L.C. has an estimated net worth of $215 Million. This is based on reported shares across multiple companies, which include IonQ, Inc., Verve Therapeutics, Inc., Decibel Therapeutics, Inc., and Prime Medicine, Inc..

SEC CIK

GV 2019 GP, L.L.C.'s CIK is 0001845038

Past Insider Trading and Trends

2021 was GV 2019 GP, L.L.C.'s most active year for acquiring shares with 3 total transactions. GV 2019 GP, L.L.C.'s most active month to acquire stocks was the month of September. 2023 was GV 2019 GP, L.L.C.'s most active year for disposing of shares, totalling 55 transactions. GV 2019 GP, L.L.C.'s most active month to dispose stocks was the month of May. 2022 saw GV 2019 GP, L.L.C. paying a total of $13,600,000.00 for 13,284,688 shares, this is the most they've acquired in one year. In 2023 GV 2019 GP, L.L.C. cashed out on 2,044,380 shares for a total of $20,007,708.65, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IonQ, Inc. (IONQ) Snapshot price: $10.36

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Prime Medicine, Inc. (PRME) Snapshot price: $6.74

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.10%
-112.82K
$15.02
-$847,744.04
10.1M
Jun 20 - Jun 21
Form 4
-1.42%
-146.38K
$14.97
-$1,092,434.97
10.16M
Jun 15 - Jun 16
Form 4
-1.10%
-114.12K
$15.00
-$855,786.85
10.23M
Jun 13 - Jun 14
Form 4
-0.61%
-63.41K
$14.73
-$467,134.63
10.29M
Jun 9 - Jun 12
Form 4
-0.39%
-40.00K
$16.33
-$332,557.00
10.32M
Jun 7 - Jun 8
Form 4
-1.00%
-104.82K
$16.86
-$884,777.42
10.34M
Jun 5 - Jun 6
Form 4
-1.18%
-123.71K
$14.01
-$876,197.61
10.39M
May 31 - Jun 1
Form 4
-0.56%
-58.81K
$13.70
-$402,843.55
10.45M
May 26 - May 30
Form 4
-0.59%
-62.12K
$13.52
-$417,893.25
10.48M
May 24 - May 25
Form 4
-2.45%
-263.72K
$14.44
-$1,889,739.36
10.51M
May 22 - May 23
Form 4
-1.55%
-167.54K
$13.32
-$1,230,337.74
10.65M
May 18 - May 19
Form 4
-0.61%
-65.65K
$12.63
-$829,275.47
10.74M
May 16 - May 17
Form 4
-1.69%
-185.24K
$12.74
-$2,359,308.93
10.8M
May 12 - May 15
Form 4
-1.03%
-114.02K
$13.82
-$1,575,337.42
10.99M
May 10 - May 11
Form 4
-3.66%
-422.01K
$14.09
-$5,946,340.40
11.1M
May 8 - May 9
Form 4
∞
13.28M
$17.00
—
13.28M
Oct 24
Form 3
—
0
—
—
0
No matching records found

Verve Therapeutics, Inc. (VERV) Snapshot price: $10.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.39%
-145.75K
$31.14
-$3,025,610.98
10.37M
Scheduled
Nov 4
Form 4
-2.19%
-234.66K
$34.23
-$5,310,657.90
10.47M
Scheduled
Nov 2 - Nov 3
Form 4
-2.36%
-256.98K
$37.79
-$6,501,030.76
10.62M
Scheduled
Oct 31 - Nov 1
Form 4
∞
4.47M
—
—
4.47M
Jun 21
Form 3
—
0
—
—
0
No matching records found

Decibel Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
819.63K
—
—
819.63K
Feb 17
Form 3
—
0
—
—
0
No matching records found